1. National Academies of Sciences, Engineering, and Medicine. E-cigarette devices, uses, exposures. In: Public Health Consequences of E-Cigarettes. Washington, DC: National Academies Press; 2018. Google Scholar
2. Family Smoking Prevention and Tobacco Control Act, §910(c), Pub L No 111-31, 123 Stat 1776 (2009). Google Scholar
3. Ramamurthi D, Gall PA, Ayoub N, Jackler RK. Leading-brand advertisement of quitting smoking benefits for e-cigarettes. Am J Public Health. 2016;106(11):20572063. LinkGoogle Scholar
4. Abrams DB, Glasser AM, Pearson JL, Villanti AC, Collins LK, Niaura RS. Harm minimization and tobacco control: reframing societal views of nicotine use to rapidly save lives. Annu Rev Public Health. 2018;39(1):193213. Crossref, MedlineGoogle Scholar
5. American Academy of Pediatrics v FDA, Memorandum and Order, Case No. PWG-18-883 (D Md 2019). Google Scholar
6. US Food and Drug Administration. FDA unveils new steps to protect youth by preventing access to flavored tobacco products, announces plans to ban menthol in cigarettes and cigars. 2018. Available at: Accessed October 12, 2018. Google Scholar
7. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review and meta-analysis. Lancet Respir Med. 2016;4(2):116128. Crossref, MedlineGoogle Scholar
8. El Dib R, Suzumura EA, Akl EA, et al. Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: a systematic review and meta-analysis [erratum in BMJ Open. 2020;10(1):e012680corr1]. BMJ Open. 2017;7(2):e012680. Google Scholar
9. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. Crossref, MedlineGoogle Scholar
10. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):20082012. Crossref, MedlineGoogle Scholar
11. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383394. Crossref, MedlineGoogle Scholar
12. Rigotti NA, Chang Y, Tindle HA, et al. Association of e-cigarette use with smoking cessation among smokers who plan to quit after a hospitalization: a prospective study. Ann Intern Med. 2018;168(9):613620. Crossref, MedlineGoogle Scholar
13. Giovenco DP, Delnevo CD. Prevalence of population smoking cessation by electronic cigarette use status in a national sample of recent smokers. Addict Behav. 2018;76:129134. Crossref, MedlineGoogle Scholar
14. Gomajee R, El-Khoury F, Goldberg M, et al. Association between electronic cigarette use and smoking reduction in France. JAMA Intern Med. 2019;179(9):11931200. CrossrefGoogle Scholar
15. Zhu SH, Zhuang YL, Wong S, Cummins SE, Tedeschi GJ. E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ. 2017;358:j3262. Crossref, MedlineGoogle Scholar
16. Halpern SD, Harhay MO, Saulsgive K, Brophy C, Troxel AB, Volp KG. A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation. N Engl J Med. 2018;378(24):23022310. Crossref, MedlineGoogle Scholar
17. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):16291637. Crossref, MedlineGoogle Scholar
18. Lucchiari C, Masiero M, Mazzocco K, et al. Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months. Addict Behav. 2020;103:106222. Crossref, MedlineGoogle Scholar
19. Walker N, Parag V, Verbiest M, Laking G, Laugesen M, Bullen C. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial. Lancet Respir Med. 2020;8(1):5464. Crossref, MedlineGoogle Scholar
20. Sterne J, Higgins J, Reeves B; ACROBAT-NRSI. A Cochrane Risk of Bias Assessment Tool: for Non-Randomized Studies of Interventions (ACROBAT-NRSI), version 1.0. 0. 24 September 2014. Google Scholar
21. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. Crossref, MedlineGoogle Scholar
22. Subialka Nowariak EN, Lien RK, Boyle RG, Amato MS, Beebe LA. E-cigarette use among treatment-seeking smokers: moderation of abstinence by use frequency. Addict Behav. 2018;77:137142. Crossref, MedlineGoogle Scholar
23. Biener L, Hargraves JL. A longitudinal study of electronic cigarette use among a population-based sample of adult smokers: association with smoking cessation and motivation to quit. Nicotine Tob Res. 2015;17(2):127133. Crossref, MedlineGoogle Scholar
24. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction. 2014;109(9):15311540. Crossref, MedlineGoogle Scholar
25. Al-Delaimy WK, Myers MG, Leas EC, Strong DR, Hofstetter CR. E-cigarette use in the past and quitting behavior in the future: a population-based study. Am J Public Health. 2015;105(6):12131219. LinkGoogle Scholar
26. Amato MS, Boyle RG, Levy D. E-cigarette use 1 year later in a population-based prospective cohort. Tob Control. 2017;26(e2):e92e96. Crossref, MedlineGoogle Scholar
27. Benmarhnia T, Pierce JP, Leas E, et al. Can e-cigarettes and pharmaceutical aids increase smoking cessation and reduce cigarette consumption? Findings from a nationally representative cohort of American smokers. Am J Epidemiol. 2018;187(11):23972404. Crossref, MedlineGoogle Scholar
28. Berry KM, Reynolds LM, Collins JM, et al. E-cigarette initiation and associated changes in smoking cessation and reduction: the Population Assessment of Tobacco and Health Study, 2013–2015. Tob Control. 2019;28(1):4249. MedlineGoogle Scholar
29. Bianco CL, Pratt SI, Ferron JC, Brunette MF. Electronic cigarette use during a randomized trial of interventions for smoking cessation among Medicaid beneficiaries with mental illness. J Dual Diagn. 2019;15(3):184191. Crossref, MedlineGoogle Scholar
30. Borderud SP, Li Y, Burkhalter JE, Sheffer CE, Ostroff JS. Electronic cigarette use among patients with cancer: characteristics of electronic cigarette users and their smoking cessation outcomes. Cancer. 2014;120(22):35273535. Crossref, MedlineGoogle Scholar
31. Bowler RP, Hansel NN, Jacobson S, et al. Electronic cigarette use in US adults at risk for or with COPD: analysis from two observational cohorts. J Gen Intern Med. 2017;32(12):13151322. Crossref, MedlineGoogle Scholar
32. Brose LS, Hitchman SC, Brown J, West R, McNeill A. Is the use of electronic cigarettes while smoking associated with smoking cessation attempts, cessation and reduced cigarette consumption? A survey with a 1-year follow-up. Addiction. 2015;110(7):11601168. Crossref, MedlineGoogle Scholar
33. Chiang SC, Abroms LC, Cleary SD, Pant I, Doherty L, Krishnan N. E-cigarettes and smoking cessation: a prospective study of a national sample of pregnant smokers. BMC Public Health. 2019;19(1):964. Crossref, MedlineGoogle Scholar
34. Christensen T, Welsh E, Faseru B. Profile of e-cigarette use and its relationship with cigarette quit attempts and abstinence in Kansas adults. Prev Med. 2014;69:9094. Crossref, MedlineGoogle Scholar
35. Curry E, Nemeth JM, Wermert A, et al. A descriptive report of electronic cigarette use after participation in a community-based tobacco cessation trial. Nicotine Tob Res. 2017;20(1):135139. Crossref, MedlineGoogle Scholar
36. Ekanem US, Cardenas VM, Cen R, et al. Electronic nicotine delivery systems and smoking cessation in Arkansas, 2014. Public Health Rep. 2017;132(2):210219. Crossref, MedlineGoogle Scholar
37. El-Khoury Lesueur F, Bolze C, Melchior M. Factors associated with successful vs. unsuccessful smoking cessation: data from a nationally representative study. Addict Behav. 2018;80:110115. Crossref, MedlineGoogle Scholar
38. Farsalinos K, Siakas G, Poulas K, Voudris V, Merakou K, Barbouni A. E-cigarette use is strongly associated with recent smoking cessation: an analysis of a representative population sample in Greece. Intern Emerg Med. 2019;14(6):835842. Crossref, MedlineGoogle Scholar
39. Flacco ME, Ferrante M, Fiore M, et al. Cohort study of electronic cigarette use: safety and effectiveness after 4 years of follow-up. Eur Rev Med Pharmacol Sci. 2019;23(1):402412. MedlineGoogle Scholar
40. Gmel G, Baggio S, Mohler-Kuo M, Daeppen JB, Studer J. E-cigarette use in young Swiss men: is vaping an effective way of reducing or quitting smoking? Swiss Med Wkly. 2016;146:w14271. MedlineGoogle Scholar
41. Gorini G, Ferrante G, Quarchioni E, et al. Electronic cigarette use as an aid to quit smoking in the representative Italian population PASSI survey. Prev Med. 2017;102:15. Crossref, MedlineGoogle Scholar
42. Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Intern Med. 2014;174(5):812813. Crossref, MedlineGoogle Scholar
43. Hefner K, Rosenheck R, Merrel J, Coffman M, Valentine G, Sofuoglu M. E-cigarette use in veterans seeking mental health and/or substance use services. J Dual Diagn. 2016;12(2):109117. Crossref, MedlineGoogle Scholar
44. Hirano T, Tabuchi T, Nakahara R, Kunugita N, Mochizuki-Kobayashi Y. Electronic cigarette use and smoking abstinence in Japan: a cross-sectional study of quitting methods. Int J Environ Res Public Health. 2017;14(2):202. CrossrefGoogle Scholar
45. Hitchman SC, Brose LS, Brown J, Robson D, McNeill A. Associations between e-cigarette type, frequency of use, and quitting smoking: findings from a longitudinal online panel survey in Great Britain. Nicotine Tob Res. 2015;17(10):11871194. Crossref, MedlineGoogle Scholar
46. Jackson SE, Kotz D, West R, Brown J. Moderators of real-world effectiveness of smoking cessation aids: a population study. Addiction. 2019;114(9):16271638. Crossref, MedlineGoogle Scholar
47. Jackson SE, Shahab L, West R, Brown J. Associations between dual use of e-cigarettes and smoking cessation: a prospective study of smokers in England. Addict Behav. 2020;103:106230. Crossref, MedlineGoogle Scholar
48. Johnson L, Ma Y, Fisher SL, et al. E-cigarette usage is associated with increased past-12-month quit attempts and successful smoking cessation in two US population-based surveys. Nicotine Tob Res. 2019;21(10):13311338. Crossref, MedlineGoogle Scholar
49. Kalkhoran S, Chang Y, Rigotti NA. Electronic cigarette use and cigarette abstinence over two years among US smokers in the Population Assessment of Tobacco and Health Study. Nicotine Tob Res. 2020;22(5):728733. Crossref, MedlineGoogle Scholar
50. Kalkhoran S, Chang Y, Rigotti NA. E-cigarettes and smoking cessation in smokers with chronic conditions. Am J Prev Med. 2019;57(6):786791. Crossref, MedlineGoogle Scholar
51. Kröger CB, Ofner S, Piontek D. Use of e-cigarettes as an additional tool in a smoking cessation group intervention: results after 12 months [in German]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61(1):3239. MedlineGoogle Scholar
52. Kulik MC, Lisha NE, Glantz SA. E-cigarettes associated with depressed smoking cessation: a cross-sectional study of 28 European Union countries. Am J Prev Med. 2018;54(4):603609. Crossref, MedlineGoogle Scholar
53. Levy DT, Yuan Z, Luo Y, Abrams DB. The relationship of e-cigarette use to cigarette quit attempts and cessation: insights from a large, nationally representative US survey. Nicotine Tob Res. 2018;20(8):931939. Crossref, MedlineGoogle Scholar
54. Little MA, Klesges RC, Bursac Z, et al. Correlates of smoking status in cancer survivors. J Cancer Surviv. 2018;12(6):828834. Crossref, MedlineGoogle Scholar
55. Manzoli L, Flacco ME, Ferrante M, et al. Cohort study of electronic cigarette use: effectiveness and safety at 24 months. Tob Control. 2017;26(3):284292. Crossref, MedlineGoogle Scholar
56. Pasquereau A, Guignard R, Andler R, Nguyen-Thanh V. Electronic cigarettes, quit attempts and smoking cessation: a 6-month follow-up. Addiction. 2017;112(9):16201628. Crossref, MedlineGoogle Scholar
57. Pearson JL, Stanton CA, Cha S, Niaura RS, Luta G, Graham AL. E-cigarettes and smoking cessation: insights and cautions from a secondary analysis of data from a study of online treatment-seeking smokers. Nicotine Tob Res. 2015;17(10):12191227. Crossref, MedlineGoogle Scholar
58. Piper ME, Baker TB, Benowitz NL, Jorenby DE. Changes in use patterns over one year among smokers and dual users of combustible and electronic cigarettes. Nicotine Tob Res. 2020;22(5):672680. Crossref, MedlineGoogle Scholar
59. Prochaska JJ, Grana RA. E-cigarette use among smokers with serious mental illness. PLoS One. 2014;9(11):e113013. Crossref, MedlineGoogle Scholar
60. Shi Y, Pierce JP, White M, et al. E-cigarette use and smoking reduction or cessation in the 2010/2011 TUS-CPS longitudinal cohort. BMC Public Health. 2016;16(1):1105. Crossref, MedlineGoogle Scholar
61. Snow E, Johnson T, Ossip DJ, et al. Does e-cigarette use at baseline influence smoking cessation rates among 2-year college students? J Smok Cessat. 2018;13(2):110120. Crossref, MedlineGoogle Scholar
62. Sutfin EL, Reboussin BA, Debinski B, Wagoner KG, Spangler J, Wolfson M. The impact of trying electronic cigarettes on cigarette smoking by college students: a prospective analysis. Am J Public Health. 2015;105(8):e83e89. LinkGoogle Scholar
63. Sweet L, Brasky TM, Cooper S, et al. Quitting behaviors among dual cigarette/e-cigarette users and cigarette smokers enrolled in the Tobacco User Adult Cohort (TUAC). Nicotine Tob Res. 2019;21(3):278284. Crossref, MedlineGoogle Scholar
64. Verplaetse TL, Moore KE, Pittman BP, et al. Intersection of e-cigarette use and gender on transitions in cigarette smoking status: findings across waves 1 and 2 of the Population Assessment of Tobacco and Health (PATH) study. Nicotine Tob Res. 2019;21(10):14231428. MedlineGoogle Scholar
65. Vickerman KA, Schauer GL, Malarcher AM, Zhang L, Mowery P, Nash CM. Reasons for electronic nicotine delivery system use and smoking abstinence at 6 months: a descriptive study of callers to employer and health plan-sponsored quitlines. Tob Control. 2017;26(2):126134. Crossref, MedlineGoogle Scholar
66. Watkins SL, Thrul J, Max W, Ling PM. Real-world effectiveness of smoking cessation strategies for young and older adults: findings from a nationally representative cohort. Nicotine Tob Res. 2020;22(9):15601568. Crossref, MedlineGoogle Scholar
67. Weaver SR, Huang J, Pechacek TF, Heath JW, Ashley DL, Eriksen MP. Are electronic nicotine delivery systems helping cigarette smokers quit? Evidence from a prospective cohort study of US adult smokers, 2015–2016. PLoS One. 2018;13(7):e0198047. Crossref, MedlineGoogle Scholar
68. Wu SY, Wang MP, Li WH, Kwong AC, Lai VW, Lam TH. Does electronic cigarette use predict abstinence from conventional cigarettes among smokers in Hong Kong? Int J Environ Res Public Health. 2018;15(3):400. CrossrefGoogle Scholar
69. Yong HH, Hitchman SC, Cummings KM, et al. Does the regulatory environment for e-cigarettes influence the effectiveness of e-cigarettes for smoking cessation?: Longitudinal findings from the ITC four country survey. Nicotine Tob Res. 2017;19(11):12681276. Crossref, MedlineGoogle Scholar
70. Young-Wolff KC, Klebaner D, Folck B, et al. Documentation of e-cigarette use and associations with smoking from 2012 to 2015 in an integrated healthcare delivery system. Prev Med. 2018;109:113118. Crossref, MedlineGoogle Scholar
71. Zawertailo L, Pavlov D, Ivanova A, Ng G, Baliunas D, Selby P. Concurrent e-cigarette use during tobacco dependence treatment in primary care settings: association with smoking cessation at three and six months. Nicotine Tob Res. 2017;19(2):183189. Crossref, MedlineGoogle Scholar
72. Zhuang YL, Cummins SE, Sun JY, Zhu SH. Long-term e-cigarette use and smoking cessation: a longitudinal study with US population. Tob Control. 2016;25(suppl 1):i90i95. Crossref, MedlineGoogle Scholar
73. Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019;380(7):629637. Crossref, MedlineGoogle Scholar
74. Hatsukami DK, Meier E, Lindgren BR, et al. A randomized clinical trial examining the effects of instructions for electronic cigarette use on smoking-related behaviors, and biomarkers of exposure. Nicotine Tob Res. 2020;22(9):15241532. Crossref, MedlineGoogle Scholar
75. Holliday R, Preshaw PM, Ryan V, et al. A feasibility study with embedded pilot randomised controlled trial and process evaluation of electronic cigarettes for smoking cessation in patients with periodontitis. Pilot Feasibility Stud. 2019;5(1):74. Crossref, MedlineGoogle Scholar
76. Lee SM, Tenney R, Wallace AW, Arjomandi M. E-cigarettes versus nicotine patches for perioperative smoking cessation: a pilot randomized trial. PeerJ. 2018;6:e5609. Crossref, MedlineGoogle Scholar
77. Lee SH, Ahn SH, Cheong YS. Effect of electronic cigarettes on smoking reduction and cessation in Korean male smokers: a randomized controlled study. J Am Board Fam Med. 2019;32(4):567574. Crossref, MedlineGoogle Scholar
78. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines 6. Rating the quality of evidence—imprecision. J Clin Epidemiol. 2011;64(12):12831293. Crossref, MedlineGoogle Scholar
79. Choi K, Forster JL. Authors’ response. Am J Prev Med. 2014;46(6):e58e59. Crossref, MedlineGoogle Scholar
80. Alzahrani T, Pena I, Temesgen N, Glantz SA. Association between electronic cigarette use and myocardial infarction [erratum in Am J Prev Med. 2019;57(4):579584]. Am J Prev Med. 2018;55(4):455–461. Google Scholar
81. Alzahrani T, Glantz SA. The association between e-cigarette use and myocardial infarction is what one would expect based on the biological and clinical evidence. Am J Prev Med. 2019;56(4):627. Crossref, MedlineGoogle Scholar
82. Alzahrani T, Glantz SA. Adding data from 2015 strengthens the association between e-cigarette use and myocardial infarction. Am J Prev Med. 2019;57(4):569571. Crossref, MedlineGoogle Scholar
83. Osei AD, Mirbolouk M, Orimoloye OA, et al. Association between e-cigarette use and cardiovascular disease among never and current combustible-cigarette smokers. Am J Med. 2019;132(8):949954.e2. Crossref, MedlineGoogle Scholar
84. Bhatta DN, Glantz SA. Association of e-cigarette use with respiratory disease among adults: a longitudinal analysis. Am J Prev Med. 2020;58(2):182190. Crossref, MedlineGoogle Scholar
85. Wills T, Soneji S, Choi K, Jaspers I, Tam E. E-cigarette use and respiratory disorder: converging evidence from epidemiological and laboratory studies. Eur Respir J. 2020:1901815; epub ahead of print November 5, 2020. Crossref, MedlineGoogle Scholar
86. Tommasi S, Caliri AW, Caceres A, et al. Deregulation of biologically significant genes and associated molecular pathways in the oral epithelium of electronic cigarette users. Int J Mol Sci. 2019;20(3):738. CrossrefGoogle Scholar
87. Miech R, Johnston L, O’Malley PM, Bachman JG, Patrick ME. Adolescent vaping and nicotine use in 2017–2018—US national estimates. N Engl J Med. 2019;380(2):192193. Crossref, MedlineGoogle Scholar
88. Leventhal AM, Miech R, Barrington-Trimis J, Johnston LD, O’Malley PM, Patrick ME. Flavors of e-cigarettes used by youths in the United States. JAMA. 2019;322(21):21322134. Crossref, MedlineGoogle Scholar
89. Barrington-Trimis JL, Urman R, Leventhal AM, et al. E-cigarettes, cigarettes, and the prevalence of adolescent tobacco use. Pediatrics. 2016;138(2):e20153983. Crossref, MedlineGoogle Scholar
90. Dutra LM, Glantz SA. E-cigarettes and national adolescent cigarette use: 2004–2014. Pediatrics. 2017;139(2):e20162450. Crossref, MedlineGoogle Scholar
91. Creamer MR, Dutra LM, Sharapova SR, et al. Effects of e-cigarette use on cigarette smoking among US youth, 2004–2018. Prev Med. 2020; Epub ahead of print. Google Scholar
92. Rao P, Liu J, Springer ML. JUUL and combusted cigarettes comparably impair endothelial function. Tob Regul Sci. 2020;6(1):3037. Crossref, MedlineGoogle Scholar
93. Gotts JE, Jordt SE, McConnell R, Tarran R. What are the respiratory effects of e-cigarettes [erratum in BMJ. 2019;367:l5980]? BMJ. 2019;366:l5275. Google Scholar
94. Siegel DA, Jatlaoui TC, Koumans EH, et al. Update: interim guidance for health care providers evaluating and caring for patients with suspected e-cigarette, or vaping, product use associated lung injury—United States, October 2019. MMWR Morb Mortal Wkly Rep. 2019;68(41):919927. Crossref, MedlineGoogle Scholar
95. Tang MS, Wu XR, Lee HW, et al. Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice [erratum in Proc Natl Acad Sci U S A. 2019;116(45):22884]. Proc Natl Acad Sci U S A. 2019;116(43):2172721731. Crossref, MedlineGoogle Scholar
96. Caliri AW, Caceres A, Tommasi S, Besaratinia A. Hypomethylation of LINE-1 repeat elements and global loss of DNA hydroxymethylation in vapers and smokers. Epigenetics. 2020;15(8):816829. Crossref, MedlineGoogle Scholar
97. Borrelli B, O’Connor GT. E-cigarettes to assist with smoking cessation. N Engl J Med. 2019;380(7):678679. Crossref, MedlineGoogle Scholar
98. Food and Drug Administration. Center for Drug Evaluation and Research application number NDA 20-714 approval letter. 1997. Available at:,%20CARTRIDE_APPROV.PDF. Accessed December 22, 2019. Google Scholar
99. Dwan K, Gamble C, Williamson PR, Kirkham JJ; Reporting Bias G. Systematic review of the empirical evidence of study publication bias and outcome reporting bias—an updated review. PLoS One. 2013;8(7):e66844. Crossref, MedlineGoogle Scholar
100. US Department of Health and Human Services. Smoking Cessation. A Report of the Surgeon General. 2020. Available at: Accessed February 8, 2020. Google Scholar


No related items




Richard J. Wang, MD, Sudhamayi Bhadriraju, MD, Stanton A. Glantz, PhDRichard J. Wang and Sudhamayi Bhadriraju were initially postdoctoral fellows in the Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of California San Francisco; Richard J. Wang subsequently joined the faculty as an assistant professor of medicine, and Sudhamayi Bhadriraju joined the pulmonary medicine staff at the Kaiser Permanente Medical Center, Redwood City, CA. Stanton A. Glantz was professor of medicine and director of the Center for Tobacco Control Research and Education at the University of California San Francisco. “E-Cigarette Use and Adult Cigarette Smoking Cessation: A Meta-Analysis”, American Journal of Public Health 111, no. 2 (February 1, 2021): pp. 230-246.

PMID: 33351653